2019—2020年成都地区慢性阻塞性肺疾病患病特征及影响因素  

Prevalence characteristics and influencing factors of COPD in Chengdu,2019-2020

作　　者：黄鑫[1] 王波[2] HUANG Xin;WANG Bo(Department of Respiratory and Critical Care Medicine,Chengdu Fifth People′s Hospital,ChengduSichuan 611130,China;Department of Cardiothoracic Surgery,Chengdu Fifth People′s Hospital,Chengdu,Sichuan 611130,China)

机构地区：[1]成都市第五人民医院呼吸与危重症医学科,成都611130 [2]成都市第五人民医院心胸外科,成都611130

出　　处：《公共卫生与预防医学》2020年第5期68-71,共4页Journal of Public Health and Preventive Medicine

摘　　要：目的探究2019—2020年间成都地区慢性阻塞性肺疾病(COPD)患者患病特征并分析其影响因素。方法采集成都地区成都市第五人民医院2019年1月至2020年1月COPD患者病历信息,共362例。分析患者病历资料,提取患者性别、年龄、住院次数、住院天数、疾病分级等信息,进行归纳分析。结果研究纳入COPD患者362例,其中男性293例,占80.94%;60岁以上COPD患者明显较59岁及其以下患者明显增多,其中高峰年龄段为60~79岁,年龄中位数为72岁;患者平均住院次数和天数分别为(8.22±8.75)次和(11.03±5.47)d;Ⅱ级和Ⅲ级COPD患者最多,共占62.83%。362例患者中,并发症共发生490例次,人均并发症1.35种。呼吸系统疾病发生394例次,心血管疾病发生74例次,其他疾病发生22例次。其中肺部感染发生频率最高,共204例次,占比56.35%;其次为肺大泡和哮喘,分别83例次和64例次,占比22.93%和17.68%。患者平喘药物使用占比最高且使用时间最长,分别为220例次(60.77%)和(10.50±6.23)d。抗生素使用119例,占32.87%,使用(7.85±5.21)d。抗凝药物仅次抗生素,使用105次,占29.01%,使用(7.54±3.18)d。logistic回归分析结果显示,有吸烟史、有被动吸烟史、年龄>50岁、有呼吸道疾病家族史和有呼吸道疾病史是影响COPD患病的独立危险因素。结论2019—2020年间成都地区COPD患者男性居多,60~79岁年龄段发病最高,肺部感染等其他呼吸系统疾病为最常见的并发症,抗生素使用符合指南推荐。Objective To explore the characteristics of chronic obstructive pulmonary diseases(COPD)in Chengdu from 2019 to 2020 and analyze its influencing factors.Methods A total of 362 patients with COPD from January 2019 to January 2020 in Chengdu Fifth People′s Hospital were collected,and the patients′medical records were analyzed.The patients′gender,age,number of hospitalizations,days of hospitalization,disease classification and other information were extracted and analyzed.Results A total of 362 COPD patients were included in this study,including 293 males,accounting for 80.94%of the total.The number of COPD patients over 60 years old was significantly higher than that of patients under 59 years old,with the largest age group being 60 to 79 years old and a median age of 72 years old.The average hospitalization times and days were(8.22±8.75)times and(11.03±5.47)days,respectively.Most patients had COPD of grade II or grade III,accounting for 62.83%of the total.In this study,there were 490 cases of complications occurring in 362 patients,with 1.35 complications per capita.There were 394 cases of respiratory diseases,74 cases of cardiovascular diseases,and 22 cases of other diseases.The incidence of pulmonary infection was the highest(204 cases,56.35%),followed by bullae and asthma(83 cases and 64 cases,22.93%and 17.68%,respectively).The proportion of antiasthmatic drug use was the highest and the use time was the longest,which was 220 times(60.77%)and(10.50±6.23)days,respectively.There were 119 cases(32.87%)treated with antibiotics for(7.85±5.21)days.The anticoagulants were used for 105 times(29.01%)and(7.54±3.18)days.Logistic regression analysis showed that smoking history,passive smoking history,age over 50 years old,family history of respiratory disease and respiratory disease history were independent risk factors for COPD.Conclusion The majority of COPD patients in Chengdu from 2019 to 2020 were male,with the highest incidence in the age group of 60-79 years.Pulmonary infection and other respiratory disea

关 键 词：慢性阻塞性肺疾病 患病特征 影响因素 

分 类 号：R181[医药卫生—流行病学]